The booming “gender-affirming care” industry suffered a devastating hit with the release of a long-awaited British review that found “remarkably weak evidence” to support treating children and young adults with gender-transition drugs and surgeries.
The report cited the “poor quality” of published research and concluded that for most young people, “a medical pathway will not be the best way to manage their gender-related distress.”
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: